Citigroup’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23M | Buy |
714,851
+176,539
| +33% | +$304K | ﹤0.01% | 2397 |
|
2025
Q1 | $1.79M | Buy |
538,312
+54,270
| +11% | +$181K | ﹤0.01% | 2161 |
|
2024
Q4 | $3.58M | Buy |
484,042
+275,278
| +132% | +$2.04M | ﹤0.01% | 1692 |
|
2024
Q3 | $1.96M | Buy |
208,764
+70,582
| +51% | +$663K | ﹤0.01% | 2056 |
|
2024
Q2 | $1.11M | Sell |
138,182
-401,713
| -74% | -$3.22M | ﹤0.01% | 2190 |
|
2024
Q1 | $8M | Sell |
539,895
-214,013
| -28% | -$3.17M | 0.01% | 996 |
|
2023
Q4 | $6.13M | Sell |
753,908
-183,511
| -20% | -$1.49M | ﹤0.01% | 1026 |
|
2023
Q3 | $4.27M | Buy |
937,419
+310,118
| +49% | +$1.41M | ﹤0.01% | 1113 |
|
2023
Q2 | $4.42M | Sell |
627,301
-635,344
| -50% | -$4.47M | ﹤0.01% | 1164 |
|
2023
Q1 | $7.71M | Buy |
1,262,645
+743,295
| +143% | +$4.54M | 0.01% | 938 |
|
2022
Q4 | $3.32M | Sell |
519,350
-50,824
| -9% | -$325K | ﹤0.01% | 1251 |
|
2022
Q3 | $5.46M | Buy |
570,174
+90,702
| +19% | +$869K | ﹤0.01% | 1078 |
|
2022
Q2 | $5.29M | Buy |
479,472
+389,174
| +431% | +$4.3M | ﹤0.01% | 1098 |
|
2022
Q1 | $1.5M | Sell |
90,298
-151,661
| -63% | -$2.53M | ﹤0.01% | 1990 |
|
2021
Q4 | $4.62M | Buy |
241,959
+119,208
| +97% | +$2.28M | ﹤0.01% | 1338 |
|
2021
Q3 | $3.03M | Sell |
122,751
-91,074
| -43% | -$2.25M | ﹤0.01% | 1601 |
|
2021
Q2 | $5.56M | Buy |
213,825
+48,618
| +29% | +$1.27M | ﹤0.01% | 1353 |
|
2021
Q1 | $5.23M | Buy |
165,207
+116,958
| +242% | +$3.7M | ﹤0.01% | 1314 |
|
2020
Q4 | $2.24M | Buy |
48,249
+7,661
| +19% | +$356K | ﹤0.01% | 1641 |
|
2020
Q3 | $1.34M | Sell |
40,588
-240,519
| -86% | -$7.92M | ﹤0.01% | 1722 |
|
2020
Q2 | $7.72M | Buy |
281,107
+159,671
| +131% | +$4.38M | 0.01% | 906 |
|
2020
Q1 | $3.64M | Buy |
121,436
+52,597
| +76% | +$1.57M | ﹤0.01% | 1081 |
|
2019
Q4 | $1.91M | Sell |
68,839
-95,547
| -58% | -$2.65M | ﹤0.01% | 1714 |
|
2019
Q3 | $2.99M | Buy |
164,386
+47,778
| +41% | +$869K | ﹤0.01% | 1342 |
|
2019
Q2 | $2.86M | Buy |
116,608
+76,831
| +193% | +$1.88M | ﹤0.01% | 1394 |
|
2019
Q1 | $378K | Sell |
39,777
-204,277
| -84% | -$1.94M | ﹤0.01% | 2699 |
|
2018
Q4 | $2.16M | Buy |
244,054
+218,275
| +847% | +$1.93M | ﹤0.01% | 1482 |
|
2018
Q3 | $289K | Buy |
25,779
+6,750
| +35% | +$75.7K | ﹤0.01% | 2905 |
|
2018
Q2 | $244K | Buy |
19,029
+870
| +5% | +$11.2K | ﹤0.01% | 2815 |
|
2018
Q1 | $307K | Sell |
18,159
-40,201
| -69% | -$680K | ﹤0.01% | 2635 |
|
2017
Q4 | $467K | Buy |
58,360
+54,095
| +1,268% | +$433K | ﹤0.01% | 2400 |
|
2017
Q3 | $33K | Buy |
4,265
+3,320
| +351% | +$25.7K | ﹤0.01% | 3822 |
|
2017
Q2 | $7K | Sell |
945
-4,743
| -83% | -$35.1K | ﹤0.01% | 4235 |
|
2017
Q1 | $42K | Sell |
5,688
-36,245
| -86% | -$268K | ﹤0.01% | 3753 |
|
2016
Q4 | $291K | Buy |
41,933
+27,242
| +185% | +$189K | ﹤0.01% | 3338 |
|
2016
Q3 | $121K | Buy |
14,691
+3,427
| +30% | +$28.2K | ﹤0.01% | 3295 |
|
2016
Q2 | $91K | Sell |
11,264
-32,413
| -74% | -$262K | ﹤0.01% | 3376 |
|
2016
Q1 | $221K | Buy |
43,677
+23,557
| +117% | +$119K | ﹤0.01% | 3393 |
|
2015
Q4 | $155K | Sell |
20,120
-354,887
| -95% | -$2.73M | ﹤0.01% | 3250 |
|
2015
Q3 | $2.16M | Sell |
375,007
-578
| -0.2% | -$3.33K | ﹤0.01% | 1276 |
|
2015
Q2 | $3.44M | Buy |
+375,585
| New | +$3.44M | ﹤0.01% | 1069 |
|